Severe radiation dermatitis associated with concomitant vemurafenib therapy in a patient with metastatic melanoma.
University of South Florida Morsani College of Medicine, Tampa, Florida.
Michael
M
Saco
University of South Florida Morsani College of Medicine, Tampa, Florida. Electronic address: mitchcl@dermatology.med.ufl.edu.
Christina
C
Mitchell
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D001859:Bone Neoplasms / Q000556:secondary* / Q000628:therapy*; D059248:Chemoradiotherapy / Q000009:adverse effects*; D005260:Female; D005269:Femur / Q000473:pathology; D005500:Follow-Up Studies; D006801:Humans; D007211:Indoles / Q000008:administration & dosage; D008545:Melanoma / Q000473:pathology / Q000556:secondary* / Q000628:therapy; D011855:Radiodermatitis / Q000175:diagnosis* / Q000188:drug therapy; D011879:Radiotherapy Dosage; D018570:Risk Assessment; D012720:Severity of Illness Index; D012878:Skin Neoplasms / Q000473:pathology* / Q000628:therapy; D013449:Sulfonamides / Q000008:administration & dosage; D016896:Treatment Outcome; D000077484:Vemurafenib
D000305:Adrenal Cortex Hormones; D007211:Indoles; D013449:Sulfonamides; D000077484:Vemurafenib